Badanie BreastSlinda®
„Observational study to evaluate the acceptability and bleeding profile with Drospirenone 4 mg, in a regimen of use 24/4 in contraception (Slinda®) after 5 cycles of use during breastfeeding. BreastSlinda® Study.”
BADANIE NIEINTERWENCYJNE